The Food and Drugs Authority (FDA) has declined insurance claims that COVID-19 screening of guests at the Kotoka International Airport (KIA) is not reliable.
This is in reaction to insurance claims by one Dr Kofi Bonney of the Noguchi Memorial Institute for Medical Study, who, according to the FDA, specified in a radio interview that the device being utilized for the screening at the airport terminal is “inaccurate and unscientific”.
Yet the FDA, in a declaration, claimed the “discovery of the SARS-CoV 2 infection at the flight terminal is not a rapid diagnostic test (RDT) kit but instead a gadget which finds the virus in nasopharyngeal (nasal) swabs.”
It clarified that the gadget detects the Antigen (SARS-CoV-2 Virus) by fluorescence modern technology.
The FDA even more said the gadget fulfilled the demands of not less than 99.0% concurrence before the authority approved it market authorisation.
Review the complete FDA statement below:
Source: Ghana Waves